Study on the clinical value of rapid detection of thyroglobulin by nano-fluorescent microsphere method

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036620

Enrollment

Unknown

Registered

2020-08-24

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Gold Standard:pathology

Index test:Rapid&#32

detection&#32

of&#32

thyroglobulin&#32

by&#32

nanofluorescent&#32

microsphere&#32

method

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old, with normal intelligence, volunteer to participate in this study, and sign an informed consent form. 2. Patients undergoing puncture for thyroid disease.

Exclusion criteria

Exclusion criteria: 1. History of thyroid or neck surgery. 2. With a history of renal disease and abnormal renal function. 3. With metabolic related bone disease. 4. Take drugs that affect thyroid metabolism, such as calcium, vitamin D, thiazide diuretics, anti-epileptics, etc.

Design outcomes

Primary

Measure	Time frame
TG;SEN, SPE, ACC, AUC of ROC, NPV, PPV;	—

Countries

China

Contacts

Public ContactYi Wanwan

Shanghai Tenth People's Hospital

1911608@tongji.cn+86 18321775325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026